Diabetes and hypertension: prognostic and therapeutic considerations.

Hypertension and diabetes are common disorders which frequently co-exist. Both are risk factors for atherosclerotic vascular disease and their combination is associated with an increased incidence of nephropathy, ischaemic heart disease, peripheral vascular disease, and stroke. Several trials such as the HDFP and SHEP studies that included diabetic patients have demonstrated the beneficial effects of antihypertensive therapy in reducing mortality. In diabetes, studies have focussed predominantly on the efficacy of antihypertensive therapy in reducing the progression of diabetic kidney disease. Such therapy has been shown to decrease albuminuria in the setting of "normal" and elevated blood pressure in both type I and type II diabetic patients. This reduction in albuminuria has been observed in microalbuminuric diabetic patients and also in those with overt renal disease. Recent studies in type I diabetic patients with overt nephropathy indicate that these effects on urinary albumin excretion are associated with reduction in the rate of decline in renal function and development of end-stage renal failure. Indeed, several groups have shown that the initiation of antihypertensive therapy improves the prognosis of type I diabetic patients with nephropathy. While certain classes of drugs may reduce the rate of progression of complications such as nephropathy, others have side effect profiles that are disadvantageous in patients with diabetes.

[1]  M. Matsuda,et al.  Effects of Angiotensin-Converting Enzyme Inhibitors, Ca2+ Channel Antagonists, and α-Adrenergic Blockers on Glucose and Lipid Metabolism in NIDDM Patients With Hypertension , 1995, Diabetes.

[2]  G. Watts,et al.  The implications of the detection of proteinuria and microalbuminuria in insulin and non-insulin dependent diabetes. , 1995, Australian and New Zealand journal of medicine.

[3]  The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group. , 1995, Journal of the American Society of Nephrology : JASN.

[4]  B. Kasiske,et al.  Effects of Antihypertensive Therapy on Serum Lipids , 1995, Annals of Internal Medicine.

[5]  B. Kasiske,et al.  Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  C. Mogensen Management of early nephropathy in diabetic patients. , 1995, Annual review of medicine.

[7]  H. Parving,et al.  Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V , 1994, Diabetes Care.

[8]  P. Poulsen,et al.  Ambulatory Blood Pressure in the Transition from Normo- to Microalbuminuria: A Longitudinal Study in IDDM Patients , 1994, Diabetes.

[9]  A. Mimran,et al.  Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases. , 1994, American journal of hypertension.

[10]  P. Weidmann,et al.  Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. , 1994, American journal of hypertension.

[11]  G. Viberti Prognostic significance of microalbuminuria. , 1994, American journal of hypertension.

[12]  B. Williams,et al.  Insulin resistance: the shape of things to come , 1994, The Lancet.

[13]  G. Jerums,et al.  Microalbuminuria: Prognostic and Therapeutic Implications in Diabetes Mellitus , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[14]  G. Jerums,et al.  Day-Night Blood Pressure Variation in Normotensive, Normoalbuminuric Type I Diabetic Subjects: Dippers and non-dippers , 1994, Diabetes Care.

[15]  H. Parving,et al.  The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. , 1994, Current opinion in nephrology and hypertension.

[16]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.

[17]  L. Groop,et al.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria , 1994 .

[18]  R. Bilous,et al.  St Vincent Declaration, 1994: Guidelines for the Prevention of Diabetic Renal Failure , 1994 .

[19]  P. Poulsen,et al.  Blood Pressure Elevation in Diabetes: Results From 24-H Ambulatory Blood Pressure Recordings in Diabetes , 1994 .

[20]  G. Maschio Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare? , 1994, Nephron.

[21]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[22]  S. Nielsen,et al.  Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  L. Appel,et al.  Ambulatory Blood Pressure Monitoring and Blood Pressure Self-Measurement in the Diagnosis and Management of Hypertension , 1993, Annals of Internal Medicine.

[24]  P. Rossing,et al.  Calcium antagonists and the diabetic hypertensive patient. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  G. Bakris,et al.  Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. , 1993, Archives of internal medicine.

[26]  M. Lishner,et al.  Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients , 1993, Annals of Internal Medicine.

[27]  C. Bulpitt,et al.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.

[28]  L. Wilkins Implications of the Systolic Hypertension in the Elderly Program: The Systolic Hypertension in the Elderly Program Cooperative Research Group , 1993, Hypertension.

[29]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[30]  J. Redón,et al.  Altered blood pressure during sleep in normotensive subjects with type I diabetes. , 1993, Hypertension.

[31]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[32]  S. Perkins,et al.  Immune complex glomerulonephritis with unusual microfibrillar deposits associated with primary bone marrow lymphoma. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  R. Schrier,et al.  Appropriate Blood Pressure Control in type II diabetes (ABCD Trial): implications for complications. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  D. Klaus The Role of Calcium Antagonists in the Treatment of Hypertension , 1992, Journal of cardiovascular pharmacology.

[35]  M. Cooper,et al.  The Management of Diabetic Proteinuria , 1992 .

[36]  H. Parving Excess mortality associated with diuretic therapy in diabetes mellitus. , 1992, Archives of internal medicine.

[37]  J. Sowers,et al.  Diabetes mellitus and hypertension. , 1992, Hypertension.

[38]  C. Mogensen,et al.  Eight to nine year mortality in known non-insulin dependent diabetics and controls. , 1992, Kidney international.

[39]  R J Jarrett,et al.  Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. , 1992, Kidney international.

[40]  H. Mulec,et al.  Renal protective effect of enalapril in diabetic nephropathy. , 1992 .

[41]  G. Bakris,et al.  A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease. , 1991, Archives of internal medicine.

[42]  C. Berne,et al.  Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors , 1991, Diabetes Care.

[43]  S. Marshall,et al.  Screening for Microalbuminuria: Which Measurement? , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[44]  R. Klein,et al.  Cause-specific mortality in a population-based study of diabetes. , 1991, American journal of public health.

[45]  H. Parving,et al.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. , 1991, BMJ.

[46]  N. Kaplan,et al.  Nonpharmacological Treatment of Hypertension in Diabetes Mellitus , 1991, Diabetes Care.

[47]  H. Black,et al.  Drug Treatment of Hypertension in Patients With Diabetes Mellitus , 1991, Diabetes Care.

[48]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[49]  R. Jarrett,et al.  Microalbuminuria and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[50]  G. Schillaci,et al.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. , 1990, Circulation.

[51]  E. Gilpin,et al.  Diabetic patients and beta-blockers after acute myocardial infarction. , 1990, European heart journal.

[52]  E. Valvo,et al.  Hemodynamic, Renal, and Humoral Effects of the Calcium Entry Blocker Nicardipine and Converting Enzyme Inhibitor Captopril in Hypertensive Type II Diabetic Patients with Nephropathy , 1989, Journal of cardiovascular pharmacology.

[53]  D. DeMets,et al.  Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? , 1989, Archives of internal medicine.

[54]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[55]  H. Parving,et al.  Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. , 1989, BMJ.

[56]  H. Parving,et al.  Prognosis in diabetic nephropathy. , 1989, BMJ.

[57]  C. Berne,et al.  Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. , 1989, BMJ.

[58]  E. O’Brien,et al.  DIPPERS AND NON-DIPPERS , 1988, The Lancet.

[59]  P. Wilson,et al.  Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure , 1988, Diabetes Care.

[60]  M. Pfeifer,et al.  α-Adrenergic Blockade Improves Glucose-Potentiated Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus , 1987, Diabetes.

[61]  F. Gennari,et al.  Hyperkalemia as a complication of drug therapy. , 1987, Archives of internal medicine.

[62]  D. Reed,et al.  Diabetes and the risk of stroke. The Honolulu Heart Program. , 1987, JAMA.

[63]  P. Wolf,et al.  Reduction of stroke through risk factor modification. , 1986, Seminars in neurology.

[64]  A. Krolewski,et al.  The changing natural history of nephropathy in type I diabetes. , 1985, The American journal of medicine.

[65]  J. Kastrup,et al.  Microalbuminuria: an early marker of renal involvement in diabetes. , 1985, Uremia investigation.

[66]  G. Viberti,et al.  Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[67]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[68]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[69]  N. Madias,et al.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. , 1983, The New England journal of medicine.

[70]  C. Mogensen Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[71]  M. Meyer,et al.  Role of risk factors in complications of diabetes mellitus. , 1980, American journal of epidemiology.

[72]  P. Bennett,et al.  Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. , 1980, The New England journal of medicine.

[73]  B. Modan,et al.  Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. , 1978, The New England journal of medicine.